Baxter 2021 Corporate Responsibility Report 61 Appendix 2030 Corporate Responsibility Goals Corporate Responsibility Commitment Empower Our Patients Protect Our Planet Champion Our People and Communities Introduction Cross-Cutting Commitments Appendix: Global Reporting Initiative (GRI) Content Index GRI 102: General Disclosures 2016 (continued) Governance 102-18 Governance structure Our Governance 102-19 Delegating authority 10 102-20 Executive-level responsibility for economic, environmental and social topics 10 102-22 Composition of the highest governance body and its committees Our Governance 102-23 Chair of the highest governance body Our Governance Organizational Profile 102-24 Nominating and selecting the highest governance body Corporate Governance Guidelines 102-25 Conflicts of interest Corporate Governance Guidelines 102-31 Review of economic, environmental and social topics 11 102-33 Communicating critical concerns Baxter 2022 Proxy Statement, (Baxter 2022 Proxy Statement Amendment) 102-35 Remuneration policies Corporate Governance Guidelines, Baxter 2022 Proxy Statement, (Baxter 2022 Proxy Statement Amendment) 102-36 Process for determining remuneration Corporate Governance Guidelines, Baxter 2022 Proxy Statement, (Baxter 2022 Proxy Statement Amendment) Stakeholder Engagement 102-40 List of stakeholder groups 11 102-42 Identifying and selecting stakeholders 11 102-43 Approach to stakeholder engagement 11 Reporting Practice 102-45 Entities included in the consolidated financial statements Baxter 2021 Annual Report on Form 10-K 102-46 Defining report content and topic Boundaries 11 102-47 List of material topics 11 102-50 Reporting period Calendar year 2021 102-51 Date of most recent report July 2021 102-52 Reporting cycle Yearly 102-53 Contact point for questions regarding the report corporate_responsibility_report@baxter.com 102-55 GRI content index This section 102-56 External assurance 2 DISCLOSURE DISCLOSURE DISCLOSURE GRI 102: General Disclosures 2016 Organizational Profile 102-1 Name of the organization 4 102-2 Activities, brands, products and services Baxter 2021 Annual Report on Form 10-K 102-3 Location of headquarters Baxter's corporate headquarters is in Deerfield, Illinois. 102-4 Location of operations Baxter 2021 Annual Report on Form 10-K 102-5 Ownership and legal form Baxter International Inc. (BAX) is a publicly traded company listed on the New York Stock Exchange. 102-6 Markets served Baxter 2021 Annual Report on Form 10-K 102-7 Scale of the organization Baxter 2021 Annual Report on Form 10-K 102-8 Information on employees and other workers 55 102-9 Supply chain 28, 54 102-10 Significant changes to the organization and its supply chain Baxter 2021 Annual Report on Form 10-K 102-11 Precautionary Principle or approach 17, 30, 34 102-12 External initiatives Examples are included throughout this report. 102-13 Membership of associations We engage with external organizations to help drive progress on a broad range of issues. Examples include Advanced Medical Technology Association, Association of Corporate Citizenship Professionals, Boston College Center for Corporate Citizenship, Business Roundtable, Ceres Company Network, Chicago United, Clean Cargo, Congressional Black Caucus Foundation, GRI Community, Health Information Sharing and Analysis Center, Healthcare Businesswomen’s Association, Healthcare Leadership Council, Healthcare Plastics Recycling Council, Medical Device Innovation Consortium, MedTech Europe, National Association for EHS&S Management, National Minority Quality Forum, National Minority Supplier Development Council, ORC HSE, Partnership for Quality Medical Donations, Pharmaceutical Supply Chain Initiative, Sustainable Healthcare Coalition, Vinyl Council of Australia and others. Strategy 102-14 Statement from senior decision-maker 3 Ethics and Integrity 102-16 Values, principles, standards and norms of behavior 20, 28, 37, 43, 45, 47, 51 102-17 Mechanisms for advice and concerns about ethics 44 2021 REPORTING 2021 REPORTING 2021 REPORTING GRI 200 Economic Standard Series GRI 201: Economic Performance 2016 GRI 103 Management Approach 2016 36, 50, 53 201-1 Direct economic value generated and distributed 36, 50, 54, 55 , Baxter 2021 Annual Report on Form 10-K 201-2 Financial implications and other risks and opportunities due to climate change Baxter CDP submission GRI 203: Indirect Economic Impacts 2016 GRI 103 Management Approach 2016 15, 36, 50, 53 203-1 Infrastructure investments and services supported 15, 36 203-2 Significant indirect economic impacts 15, 36, 50 GRI 205: Anticorruption 2016 GRI 103 Management Approach 2016 43, 53 205-1 Operations assessed for risks related to corruption 44 205-2 Communication and training about anticorruption policies and procedures 43 GRI 300 Environmental Standards Series GRI 301: Materials 2016 GRI 103 Management Approach 2016 30, 32, 34, 53 301-3 Reclaimed products and their packaging materials 32 GRI 302: Energy 2016 GRI 103 Management Approach 2016 23, 53 302-1 Energy consumption within the organization 23, 54, 56 302-3 Energy intensity 54 302-4 Reduction of energy consumption 23 GRI 303: Water and Effluents 2018 GRI 103 Management Approach 2016 25, 53 303-3 Water withdrawal 26, 54 303-4 Water discharge 54 This index references information related to disclosures from the GRI Sustainability Reporting Standards. The reported information may meet in part or in full the requirements of each GRI disclosure listed.